Study of patients with melanoma finds most have few moles

March 2, 2016
Melanoma in skin biopsy with H&E stain — this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0

Most patients with melanoma had few moles and no atypical moles, and in patients younger than 60, thick melanomas were more commonly found in those with fewer moles but more atypical moles, according to an article published online by JAMA Dermatology.

Studies have suggested that the number of total moles and atypical moles is associated with the risk of . Yet the relationship of those mole patterns with tumor thickness and cancer prognosis is complex.

Alan C. Geller, M.P.H., R.N., of the Harvard T.H. Chan School of Public Health, Boston, and coauthors looked at the association between age and total moles and atypical moles and whether there was a relationship between total moles or atypical moles and tumor thickness, a very important prognostic indicator for melanoma.

The study included 566 patients with melanoma and most of them (66.4 percent or 376) had zero to 20 total moles, while 73.3 percent (415 patients) had no atypical moles.

In patients younger than 60, having more than 50 total moles was associated with reduced risk for thick melanoma, while having more than five atypical moles compared with no atypical moles was associated with thicker melanoma, according to the results.

"Several public health messages emerge from our study, including that melanomas are more commonly diagnosed in individuals with fewer nevi compared with those with a high mole count. Therefore, physicians and patients should not rely on the total nevus count as a sole reason to perform skin examinations or to determine a patient's at-risk status," the study concludes.

Explore further: People with few moles apt to develop deadlier skin cancer, study finds

More information: JAMA Dermatology. Published online March 2, 2016. DOI: 10.1001/jamadermatol.2016.0027

Related Stories

People with few moles apt to develop deadlier skin cancer, study finds

August 20, 2015
(HealthDay)—People who have many moles are at increased risk for melanoma skin cancer, but people with fewer moles may be more likely to develop a more aggressive form of the disease, a new study suggests.

Moles can quadruple risk of developing melanoma

September 4, 2014
Having moles on your skin can quadruple your risk of developing melanoma, the deadliest type of skin cancer, according to a study released this week by experts at the University of Melbourne, University of Oxford, and the ...

More than 11 moles on your arm could indicate higher risk of melanoma

October 19, 2015
Researchers at King's College London have investigated a new method that could be used by GPs to quickly determine the number of moles on the entire body by counting the number found on a smaller 'proxy' body area, such as ...

Mobile teledermoscopy for short-term monitoring of atypical moles

January 28, 2015
Allowing patients to use mobile devices to capture skin images appears to be a feasible and effective method for short-term monitoring of atypical nevi (moles), according to an article published online by JAMA Dermatology.

Recommended for you

Bolstering fat cells offers potential new leukemia treatment

October 16, 2017
Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.

Study reveals complex biology, gender differences, in kidney cancer

October 13, 2017
A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth further investigation.

Cholesterol byproduct hijacks immune cells, lets breast cancer spread

October 12, 2017
High cholesterol levels have been associated with breast cancer spreading to other sites in the body, but doctors and researchers don't know the cause for the link. A new study by University of Illinois researchers found ...

New drug hope for rare bone cancer patients

October 12, 2017
Patients with a rare bone cancer of the skull and spine - chordoma - could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal ...

Scientists pinpoint surprising origin of melanoma

October 12, 2017
Led by Jean-Christophe Marine (VIB-KU Leuven), a team of researchers has tracked down the cellular origin of cutaneous melanoma, the deadliest form of skin cancer. The team was surprised to observe that these very aggressive ...

Team finds a potentially better way to treat liver cancer

October 12, 2017
A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.